1. Home
  2. APLS vs DNP Comparison

APLS vs DNP Comparison

Compare APLS & DNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • DNP
  • Stock Information
  • Founded
  • APLS 2009
  • DNP 1986
  • Country
  • APLS United States
  • DNP United States
  • Employees
  • APLS N/A
  • DNP N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • DNP Investment Managers
  • Sector
  • APLS Health Care
  • DNP Finance
  • Exchange
  • APLS Nasdaq
  • DNP Nasdaq
  • Market Cap
  • APLS 3.5B
  • DNP 3.7B
  • IPO Year
  • APLS 2017
  • DNP N/A
  • Fundamental
  • Price
  • APLS $27.97
  • DNP $9.89
  • Analyst Decision
  • APLS Buy
  • DNP
  • Analyst Count
  • APLS 20
  • DNP 0
  • Target Price
  • APLS $34.11
  • DNP N/A
  • AVG Volume (30 Days)
  • APLS 3.0M
  • DNP 488.0K
  • Earning Date
  • APLS 07-31-2025
  • DNP 01-01-0001
  • Dividend Yield
  • APLS N/A
  • DNP 7.89%
  • EPS Growth
  • APLS N/A
  • DNP N/A
  • EPS
  • APLS N/A
  • DNP 2.30
  • Revenue
  • APLS $754,649,000.00
  • DNP $154,887,179.00
  • Revenue This Year
  • APLS $10.84
  • DNP N/A
  • Revenue Next Year
  • APLS $10.51
  • DNP N/A
  • P/E Ratio
  • APLS N/A
  • DNP $4.29
  • Revenue Growth
  • APLS 20.02
  • DNP 3.30
  • 52 Week Low
  • APLS $16.10
  • DNP $8.69
  • 52 Week High
  • APLS $41.94
  • DNP $10.04
  • Technical
  • Relative Strength Index (RSI)
  • APLS 74.59
  • DNP 58.35
  • Support Level
  • APLS $26.23
  • DNP $9.83
  • Resistance Level
  • APLS $28.87
  • DNP $9.88
  • Average True Range (ATR)
  • APLS 1.07
  • DNP 0.05
  • MACD
  • APLS 0.18
  • DNP 0.00
  • Stochastic Oscillator
  • APLS 84.04
  • DNP 92.87

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About DNP DNP Select Income Fund Inc.

DNP Select Income Fund Inc is a closed-ended investment management fund. The primary investment objectives of the fund are current income and long-term growth of income. Its secondary objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing in the public utility industry.

Share on Social Networks: